These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15658670)

  • 21. Autotransplant tissue selection criteria with or without stereomicroscopy in parathyroidectomy for treatment of renal hyperparathyroidism.
    Ohe MN; Santos RO; Neves MC; Carvalho AB; Kunii IS; Abrahão M; Cervantes O; Lazaretti-Castro M; Vieira JG
    Braz J Otorhinolaryngol; 2014; 80(4):318-24. PubMed ID: 25183182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.
    Mizobuchi M; Ogata H; Koiwa F
    Ther Apher Dial; 2019 Aug; 23(4):309-318. PubMed ID: 30411503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary hyperparathyroidism in chronic renal failure. Pathophysiology and treatment.
    Hanley DA; Sherwood LM
    Med Clin North Am; 1978 Nov; 62(6):1319-39. PubMed ID: 368449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation.
    Jean G; Vanel T; Terrat JC; Chazot C
    Hemodial Int; 2010 Oct; 14(4):486-91. PubMed ID: 20955282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hypercalcemia after renal transplantation.
    Torregrosa JV; Barros X
    Nefrologia; 2013 Nov; 33(6):751-7. PubMed ID: 24241361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes.
    Mathur A; Sutton W; Ahn JB; Prescott JD; Zeiger MA; Segev DL; McAdams-DeMarco M
    Transplantation; 2021 Dec; 105(12):e366-e374. PubMed ID: 33534525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid surgery in renal failure patients.
    Dumasius V; Angelos P
    Otolaryngol Clin North Am; 2010 Apr; 43(2):433-40, x-xi. PubMed ID: 20510725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
    Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
    Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up.
    Puccini M; Carpi A; Cupisti A; Caprioli R; Iacconi P; Barsotti M; Buccianti P; Mechanick J; Nicolini A; Miccoli P
    Biomed Pharmacother; 2010 May; 64(5):359-62. PubMed ID: 20435429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
    Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 33. Spontaneous remission of severe hyperparathyroidism in chronic renal failure.
    Charhon S; Sellem C; Meunier PJ; Traeger J
    Nephron; 1983; 33(1):53-5. PubMed ID: 6835455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of secondary hyperparathyroidism in renal allograft recipients.
    Wilson RE; Hampers CL; Katz AI; Bernstein DS; Wachman A; Merrill JP; Murray JE
    Transplant Proc; 1969 Mar; 1(1):206-8. PubMed ID: 4944219
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
    Soomro IH; Goldfarb DS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic strategies for secondary hyperparathyroidism in dialysis patients.
    Ogata H; Koiwa F; Ito H; Kinugasa E
    Ther Apher Dial; 2006 Aug; 10(4):355-63. PubMed ID: 16911189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].
    Fukagawa M
    Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1245-50. PubMed ID: 10465972
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
    Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The need for better control of secondary hyperparathyroidism.
    Locatelli F
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V15-19. PubMed ID: 15284355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.